Literature DB >> 28476637

The critical role of Nramp1 in degrading α-synuclein oligomers in microglia under iron overload condition.

Kuo-Chen Wu1, Horng-Huei Liou2, Yu-Han Kao1, Chih-Yu Lee1, Chun-Jung Lin3.   

Abstract

Oligomeric α-synuclein is a key mediator in the pathogenesis of Parkinson's disease (PD) and is mainly cleared by autophagy-lysosomal pathway, whose dysfunction results in the accumulation and cell-to-cell transmission of α-synuclein. In this study, concomitant with the accumulation of iron and oligomeric α-synuclein, higher expression of a lysosomal iron transporter, natural resistance-associated macrophage protein-1 (Nramp1), was observed in microglia in post-mortem striatum of sporadic PD patients. Using Nramp1-deficient macrophage (RAW264.7) and microglial (BV-2) cells as in-vitro models, iron exposure significantly reduced the degradation rate of the administered human α-synuclein oligomers, which can be restored by the expression of the wild-type, but not mutant (D543N), Nramp1. Likewise, under iron overload condition, mice with functional Nramp1 (DBA/2 and C57BL/6 congenic mice carrying functional Nramp1) had a better ability to degrade infused human α-synuclein oligomers than mice with nonfunctional Nramp1 (C57BL/6) in the brain and microglia. The interplay between iron and Nramp1 exhibited parallel effects on the clearance of α-synuclein and the activity of lysosomal cathepsin D in vitro and in vivo. Collectively, these findings suggest that the function of Nramp1 contributes to microglial degradation of oligomeric α-synuclein under iron overload condition and may be implicated in the pathogenesis of PD.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Iron; Microglia; Nramp1; Oligomeric α-synuclein; Parkinson's disease

Mesh:

Substances:

Year:  2017        PMID: 28476637     DOI: 10.1016/j.nbd.2017.05.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  6 in total

Review 1.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

Review 2.  Eat Prey, Live: Dictyostelium discoideum As a Model for Cell-Autonomous Defenses.

Authors:  Joe Dan Dunn; Cristina Bosmani; Caroline Barisch; Lyudmil Raykov; Louise H Lefrançois; Elena Cardenal-Muñoz; Ana Teresa López-Jiménez; Thierry Soldati
Journal:  Front Immunol       Date:  2018-01-04       Impact factor: 7.561

Review 3.  Microglia Response During Parkinson's Disease: Alpha-Synuclein Intervention.

Authors:  Sara A Ferreira; Marina Romero-Ramos
Journal:  Front Cell Neurosci       Date:  2018-08-06       Impact factor: 5.505

4.  The Contribution of Iron to Protein Aggregation Disorders in the Central Nervous System.

Authors:  Karina Joppe; Anna-Elisa Roser; Fabian Maass; Paul Lingor
Journal:  Front Neurosci       Date:  2019-01-22       Impact factor: 4.677

5.  Single-cell sequencing of human midbrain reveals glial activation and a Parkinson-specific neuronal state.

Authors:  Semra Smajić; Cesar A Prada-Medina; Zied Landoulsi; Jenny Ghelfi; Sylvie Delcambre; Carola Dietrich; Javier Jarazo; Jana Henck; Saranya Balachandran; Sinthuja Pachchek; Christopher M Morris; Paul Antony; Bernd Timmermann; Sascha Sauer; Sandro L Pereira; Jens C Schwamborn; Patrick May; Anne Grünewald; Malte Spielmann
Journal:  Brain       Date:  2022-04-29       Impact factor: 15.255

Review 6.  Neurons and Glia Interplay in α-Synucleinopathies.

Authors:  Panagiota Mavroeidi; Maria Xilouri
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.